Tissue Regenix
Tissue Regenix researches and develops decellularisation-based tissue regenerative medicines for trauma, orthopedic and dental surgical procedures.
Business Model:
Revenue: $17.4M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Tissue Regenix Information
Geographic Data
Address: Astley Way, Swillington
City: Leeds
State: england
Zip: LS26 8XT
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$18M
Raised Total:$19M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Tissue Regenix researches and develops decellularisation-based tissue regenerative medicines for trauma, orthopedic and dental surgical procedures.
Contact Phone:
+12106599353
Contact Email:
Tissue Regenix went public on 7/9/2010 on the London Stock Exchange
Listed Exchange:
London Stock Exchange
IPO Date:
7/9/2010
Ticker Symbol:
TRX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2007 | Venture Round | 3 | $1.3M |
Aquarius Equity Partners White Rose Technology Seedcorn Fund IP Group Aquarius Equity Partners White Rose Technology Seedcorn Fund IP Group |
5/2020 | Post-IPO Equity | $17.8M | 4/2020 | Debt | $1M | 6/2019 | Debt | $20M |
MidCap Financial Trust |
6/2011 | Grant | $324.2k |
European Commission |
7/2017 | Equity | $52M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2017 | CellRight Technologies |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
